TITLE

Development of bioartificial myocardium by electrostimulation of 3D collagen scaffolds seeded with stem cells

AUTHOR(S)
Haneef, Kanwal; Lila, Nermine; Benadda, Samira; Legrand, Fabien; Carpentier, Alain; Chachques, Juan C.
PUB. DATE
July 2012
SOURCE
Heart International;Jul2012, Vol. 7 Issue 2, p70
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Electrostimulation (ES) can be defined as a safe physical method to induce stem cell differentiation. The aim of this study is to evaluate the effectiveness of ES on bone marrow mesenchymal stem cells (BMSCs) seeded in collagen scaffolds in terms of proliferation and differentiation into cardiomyocytes. BMSCs were isolated from Wistar rats and seeded into 3D collagen type 1 templates measuring 25 x 25 x 6 mm. Bipolar in vitro ES was performed during 21 days. Electrical impedance and cell proliferation were measured. Expression of cardiac markers was assessed by immunocyto- chemistry. Viscoelasticity of collagen matrix was evaluated. Electrical impedance assessments showed a low resistance of 234±41 Ohms which indicates good electrical conductivity of collagen matrix. Cell proliferation at 570 nm as significantly increased in ES groups after seven day (ES 0.129±0.03 vs non-stimulated control matrix 0.06±0.01, P=0.002) and after 21 days, (ES 0.22±0.04 vs control 0.13±0.01, P=0.01). Immunocytoche mistry of BMSCs after 21 days ES showed positive stain- ing of cardiac markers, troponin I, connexin 43, sarcomeric alpha-actinin, slow myosin, fast myosin and desmin. Staining for BMSCs marker CD29 after 21 days was negative. Electrostimulation of cell-seeded collagen matrix changed stem cell morphology and biochemical characteristics, increasing the expression of cardiac markers. Thus, MSC-derived differentiated cells by electrostimulation grafted in biological scaffolds might result in a convenient tissue engineering source for myocardial diseases.
ACCESSION #
80417011

 

Related Articles

  • Is the Therapeutic Potential of Stem Cells for Myocardial Regeneration Limited by Proarrhythmic Effects? Wolfram, Oliver; Hammw�hner, Matthias; Goette, Andreas // Current Cardiology Reviews;2007, Vol. 3 Issue 4, p283 

    Stem cells have recently gained attention within Cardiology for their therapeutical application as a treatment in acute myocardial infarction and heart failure. Especially for larger infarct areas, direct myocardial application of bonemarrow derived progenitor cells or the subcutaneous treatment...

  • Impact of cardiac stem cell sheet transplantation on myocardial infarction. Alshammary, Sfoug; Fukushima, Satsuki; Miyagawa, Shigeru; Matsuda, Takenori; Nishi, Hiroyuki; Saito, Atsuhiro; Kamata, Sokichi; Asahara, Takayuki; Sawa, Yoshiki // Surgery Today;Sep2013, Vol. 43 Issue 9, p970 

    Purpose: Myocardial infarction (MI) remains a major cause of mortality because of the limited regenerative capacity of the myocardium. Transplantation of somatic tissue-derived cells into the heart has been shown to enhance the endogenous healing process, but the magnitude of its therapeutic...

  • Donor stem cells explored in post-heart attack therapy.  // Cardiovascular Devices & Drugs;May2008, Vol. 14 Issue 5, p34 

    The article focuses on a study which found that a type of stem cell promotes better healing in heart attack patients while also acting to stave off congestive heart failure (CHF) which could be developed by patients following a heart attack. The stem cells used in this study are known as...

  • Cardiac stem cell research still active.  // CMAJ: Canadian Medical Association Journal;1/6/2009 Conference Reports, Vol. 180, p7 

    The article offers information on the updates and developments of cardiac clinical trials involving stem cells for better management of acute myocardial infarction (AMI) and congestive heart failure (CHF). It is mentioned that stem cell research to date has provided future prospects in...

  • New directions in strategies using cell therapy for heart disease. Itescu, Silviu; Schuster, Michael D.; Kocher, Alfred A. // Journal of Molecular Medicine;May2003, Vol. 81 Issue 5, p288 

    Congestive heart failure remains a major public health problem and is frequently the end result of cardiomyocyte apoptosis and fibrous replacement after myocardial infarction, a process referred to as left ventricular remodeling. Cardiomyocytes undergo terminal differentiation soon after birth...

  • Cellular therapy promotes endogenous stem cell repair.  // Canadian Journal of Physiology & Pharmacology;Oct2012, Vol. 90 Issue 10, p1335 

    Cellular transplantation for cardiac repair has emerged as an exciting treatment option for patients with myocardial infarction (MI) and heart failure. Animal models of post-infarction left ventricular remodeling have demonstrated an improvement in left ventricular (LV) function, decrease in...

  • Mesoblast's Stem Cell Therapy Works in Phase II HF Trial. Moran, Nuala // BioWorld International;11/16/2011, Vol. 16 Issue 46, p1 

    The article reports that Mesoblast Ltd. has delivered positive results in a 60-patient Phase II trial of Revascor in congestive heart trial and has revived hopes for the potential use of stem cells to treat heart disease. Revascor did not provoke any adverse immune responses. There was a...

  • Cellular Therapy for Myocardial Repair. Feygin, Julia; Mhashilkar, Abner M.; Deans, Robert; Jianyi Zhang // Current Cardiology Reviews;2007, Vol. 3 Issue 2, p121 

    Post infarction left ventricular remodeling is a compensatory response to an acute myocardial infarction that is characterized by left ventricular dilation and myocardial hypertrophy. Although stable left ventricular remodeling may be achieved for a period of time, progressive myocardial...

  • Cardiac Cell Therapy: The Next (Re)Generation. Forte, Elvira; Chimenti, Isotta; Barile, Lucio; Gaetani, Roberto; Angelini, Francesco; Ionta, Vittoria; Messina, Elisa; Giacomello, Alessandro // Stem Cell Reviews & Reports;Dec2011, Vol. 7 Issue 4, p1018 

    Heart failure remains one of the main causes of morbidity and mortality in the Western world. Current therapies for myocardial infarction are mostly aimed at blocking the progression of the disease, preventing detrimental cardiac remodeling and potentiating the function of the surviving tissue....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics